Lung infections after cancer chemotherapy (Q37345694)

19 August 2017

1 reference

title

Lung infections after cancer chemotherapy (English)

1 reference

19 August 2017

1 reference

Francesca Cainelli

2

0 references

Sandro Vento

object named as

Sandro Vento

series ordinal

1

0 references

author name string

Zelalem Temesgen

series ordinal

3

1 reference

19 August 2017

1 October 2008

1 reference

Lancet Oncology Commission

19 August 2017

1 reference

19 August 2017

9

1 reference

19 August 2017

10

1 reference

19 August 2017

982-992

1 reference

Pulmonary infiltrations in febrile patients with neutropenia. Risk factors and outcome under empirical antimicrobial therapy in a randomized multicenter study

19 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Potential sites of infection that develop in febrile neutropenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Suppressed neutrophil function as a risk factor for severe infection after cytotoxic chemotherapy in patients with acute nonlymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Bronchoalveolar lavage and the immunology of primary lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Defective cytostatic activity of pulmonary alveolar macrophages in primary lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Fever and infection in leukemic patients.A study of 494 consecutive patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Prognostic factors influencing mortality in cancer patients with neutropenia and bacteremia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Community respiratory virus infections in immunocompromised patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Role of flexible bronchoscopy in immunocompromised patients with lung infiltrates

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Fiberoptic bronchoscopy and bronchoalveolar lavage for the evaluation of pulmonary disease in children with primary immunodeficiency and cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Noninfectious lung disease in the immunocompromised host

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Pulmonary drug toxicity: radiologic and pathologic manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Early detection of pneumonia in febrile neutropenic patients: use of thin-section CT.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Acute lung disease in the immunocompromised host: CT and pathologic examination findings.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Bronchoscopic diagnosis of pulmonary infiltrates in granulocytopenic patients with hematologic malignancies: BAL versus PSB and PBAL.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Use of first line bronchoalveolar lavage in the immunosuppressed oncology patient

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Open lung biopsy provides a higher and more specific diagnostic yield compared to broncho-alveolar lavage in immunocompromised patients. Fungal Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Prognostic factors of non-HIV immunocompromised patients with pulmonary infiltrates.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Review of the incidence and prognosis of Pseudomonas aeruginosa infections in cancer patients in the 1990s

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Clinical features of Stenotrophomonas maltophilia pneumonia in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Stenotrophomonas maltophilia pneumonia in cancer patients without traditional risk factors for infection, 1997-2004

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Diagnosis of nosocomial pneumonia in cancer patients undergoing mechanical ventilation: a prospective comparison of the plugged telescoping catheter with the protected specimen brush

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Pulmonary nocardiosis: Risk factors and outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Nocardiosis in a teaching hospital in the Central Anatolia region of Turkey: treatment and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Clinical experience with linezolid for the treatment of nocardia infection

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

A case series and focused review of nocardiosis: clinical and microbiologic aspects

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Severe Chlamydia pneumoniae infection in patients with neutropenia: case reports and literature review

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Severe Chlamydia pneumoniae infection in a patient with mild neutropenia during treatment of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Atypical mycobacterial infections in children with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Bacteremic Pneumonia in Neutropenic Patients With Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Characteristics and outcome of respiratory syncytial virus infection in patients with leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Cytomegalovirus pneumonia in adults with leukemia: an emerging problem

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Cytomegalovirus viremia during Campath-1H therapy for relapsed and refractory chronic lymphocytic leukemia and prolymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Pulmonary cytomegalovirus infection in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Rapid detection of cytomegalovirus pulmonary infection by bronchoalveolar lavage and centrifugation culture

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Diagnosis and treatment approaches of CMV infections in adult patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Correlation between viral loads of cytomegalovirus in blood and bronchoalveolar lavage specimens from lung transplant recipients determined by histology and immunohistochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Detection and typing by molecular techniques of respiratory viruses in children hospitalized for acute respiratory infection in Rome, Italy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Brief communication: fatal human metapneumovirus infection in stem-cell transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Upper and lower respiratory tract infections by human enterovirus and rhinovirus in adult patients with hematological malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Aspergillosis case-fatality rate: systematic review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Plasmalyte as a cause of false-positive results for Aspergillus galactomannan in bronchoalveolar lavage fluid

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Diagnosis and treatment of invasive pulmonary aspergillosis in neutropenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Clinical evaluation of a polymerase chain reaction assay to detect Aspergillus species in bronchoalveolar lavage samples of neutropenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Role of fiberoptic bronchoscopy in the diagnosis of invasive pulmonary aspergillosis in patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Early detection of aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screening.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Use of galactomannan enzyme immunoassay for diagnosis of invasive aspergillosis in a tertiary-care center over a 12-month period

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Treatment failure in invasive aspergillosis: susceptibility of deep tissue isolates following treatment with amphotericin B.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Efficacy and toxicity of intermediate-dose amphotericin B lipid complex as a primary or salvage treatment of fungal infections in patients with hematological malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Invasive aspergillosis in neutropenic patients: rapid neutrophil recovery is a risk factor for severe pulmonary complications

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

In situ hybridization for the differentiation of Aspergillus, Fusarium, and Pseudallescheria species in tissue section

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Scedosporiosis in patients with acute leukemia: a retrospective multicenter report.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

In vitro activities of four novel triazoles against Scedosporium spp

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Nonsurgical cure of pulmonary mucormycosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Influence of type of cancer and hematopoietic stem cell transplantation on clinical presentation of Pneumocystis jiroveci pneumonia in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Peripheral blood CD4 + T-lymphocyte counts during Pneumocystis carinii pneumonia in immunocompromised patients without HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

Polymicrobial infection in patients with cancer: an underappreciated and underreported entity

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970255-9

7 January 2021

10.1016/S1470-2045(08)70255-9

Identifiers

DOI

1 reference

19 August 2017

1 reference

PubMed ID

19071255